Discover a study that demonstrates the effectiveness of guselkumab in treating scalp psoriasis, offering significant symptom ...

Researchers evaluated the efficacy and safety of icotrokinra for treating plaque psoriasis affecting the scalp, genital, and/or hand/foot areas.

Psoriasis can occur near the eyes, causing redness, itching, dryness, and flaking skin. Once it’s correctly diagnosed, you can often manage it with topical treatments.

Patients with psoriasis who had low body surface area (BSA) involvement experienced similarly poor QOL and symptom burden compared to patients with higher BSA.

U.K. adults with psoriasis may be compromising their health and risking exacerbating their skin condition by seeking ...

Psoriasis often affects the scalp, elbows, and knees, but it can also involve more sensitive areas like the face, palms, soles of the feet, armpits, groin, genitals, and underneath the breasts ...

Scalp psoriasis is an autoimmune condition that may be worsened by poor hygiene but isn’t caused by it. A dermatologist debunks various myths surrounding the condition. Written by: Tenzin Chodon ...

In the ARRECTOR trial, 66.4% of individuals treated with Zoryve foam versus 27.8% treated with a matching vehicle foam achieved Scalp-IGA success ("clear" or "almost clear" plus a 2-point ...

Arcutis Biotherapeutics has received FDA approval for ZORYVE (roflumilast) topical foam 0.3%, which is now available for treating plaque psoriasis on the scalp and body in patients aged 12 and ...

Source Reference: Gooderham MJ, et al "Roflumilast foam, 0.3%, for psoriasis of the scalp and body: The ARRECTOR phase 3 randomized clinical trial" JAMA Dermatol 2025; DOI: 10.1001/jamadermatol ...

Icotrokinra led to high rates of skin clearance in patients with scalp and genital psoriasis, according to results from the ICONIC-TOTAL study. Icotrokinra is an investigational oral peptide that ...